GM26075
LCL from B-Lymphocyte
Description:
MYHRE SYNDROME; MYHRS
MOTHERS AGAINST DECAPENTAPLEGIC, DROSOPHILA, HOMOLOG OF, 4; SMAD4
|
Repository
|
NIGMS Human Genetic Cell Repository
|
| Subcollection |
Heritable Diseases
Hereditary Cancers |
|
Biopsy Source
|
Peripheral vein
|
|
Cell Type
|
B-Lymphocyte
|
|
Tissue Type
|
Blood
|
|
Transformant
|
Epstein-Barr Virus
|
|
Sample Source
|
LCL from B-Lymphocyte
|
|
Race
|
White
|
|
Ethnicity
|
Not Hispanic/Latino
|
|
Ethnicity
|
Old Order Amish
|
|
Country of Origin
|
USA
|
|
Family Member
|
1
|
|
Family History
|
N
|
|
Relation to Proband
|
proband
|
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
|
Species
|
Homo sapiens
|
|
Common Name
|
Human
|
|
Remarks
|
|
| IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
| |
| Gene |
SMAD4 |
| Chromosomal Location |
18q21.2 |
| Allelic Variant 1 |
; MYHRE SYNDROME |
| Identified Mutation |
c.1182_1197delAGGTGATGTTTGGGTC |
| Remarks |
Clinically affected; onset of symptoms at 6 weeks of age; diagnosed at 2 years of age by geneticist; dysmorphic features include: tall narrow forehead, almond-shaped eyes, anteverted nares, low-set ears, cupid-bow mouth, and high-arched palate; hypotonia; dysphagia; conductive hearing loss; gross motor and fine motor delay; L1 and L2 vertebral abnormality; Affymetrix CytoScan -normal; both whole exome sequencing and Sanger sequencing revealed donor subject to be heterozygous for the following mutation in SMAD4: c.1182_1197delAGGTGATGTTTGGGTC; treatment and management: physical, occupational, and speech language therapies; unaffected mother is GM26076. |
| Split Ratio |
1:4 |
| Temperature |
37 C |
| Percent CO2 |
5% |
| Percent O2 |
AMBIENT |
| Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
| Serum |
15% fetal bovine serum Not Inactivated |
| Substrate |
None specified |
| Subcultivation Method |
dilution - add fresh medium |
| Supplement |
- |
|
|